Pfizer Licenses Ariadne's Pathway Studio Software | GenomeWeb
NEW YORK (GenomeWeb News) – Pfizer has bought a multi-site license for Ariadne’s Pathway Studio Enterprise software, which is used to import and analyze microarray and proteomics data and includes the ResNet database, Rockville, Md.-based Ariadne said yesterday.
 
Pfizer plans to use the software to assemble reference networks of interactions from internal and public data sources to interpret experimental results in its labs.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.